USPH

Business Context and Reporting Period

Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2006
Business Overview: The Company operates outpatient physical and occupational therapy clinics. As of September 30, 2006, it operated 282 clinics in 40 states. The Company primarily operates through subsidiary clinic partnerships where it holds a majority interest, with managing therapists holding minority interests.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net revenues increased 0.8% in the third quarter and 7.7% for the nine months ended September 30, 2006, compared to the prior year periods. This was driven by a 1.9% increase in patient visits in Q3 and a 7.7% increase for the nine-month period.
• Profitability Decline: Net income decreased significantly due to discontinued operations. For the nine months ended September 30, 2006, net income was $4.2 million compared to $7.2 million in the prior year. This decline is primarily attributed to a $1.9 million net loss from discontinued operations (closure of 31 unprofitable clinics).
• Operating Costs: Clinic operating costs as a percentage of net revenues increased to 75.5% in Q3 2006 from 71.3% in Q3 2005. Salaries and related costs rose due to new clinic openings and market demand for therapists.
• Discontinued Operations: The Company closed 31 unprofitable clinics during the first nine months of 2006 (28 in Q3). These closures resulted in pre-tax charges of $1.9 million, including lease commitments, asset write-offs, and severance.

Guidance, Outlook, and Risks

• Medicare Reimbursement Risk: A significant risk identified is the final CMS rule for 2007, which projects a 10% reduction in reimbursement for outpatient therapy services and a $1,780 therapy cap with no exception process. Management estimates this could result in a revenue reduction of more than $2.5 million annually unless offset by business expansion or legislative changes.
• Outlook: The Company expects to continue opening new clinics and acquiring minority interests. It anticipates initial operating losses for new clinics opened in 2006, with favorable impacts expected to begin in 2007.
• Liquidity: Management believes cash equivalents ($15.9 million including marketable securities) and cash flows from operations are sufficient to fund operations, clinic development, and closure costs through at least September 2007. The Company has a $5.0 million unsecured credit facility with no outstanding balance as of the filing date.
• Accounting Changes: The Company adopted SFAS 123R (Share-Based Payment) effective January 1, 2006, resulting in a non-cash compensation expense of $0.7 million for the nine months ended September 30, 2006.

Investor Verification Checklist

• Medicare Cap Impact: Verify the actual financial impact of the 2007 Medicare reimbursement cuts and the elimination of the exception process on future revenue projections.
• Clinic Closure Costs: Confirm the remaining accrued liabilities for lease commitments ($0.9 million) associated with the 31 closed clinics and the timeline for payments.
• Stock-Based Compensation: Review the impact of SFAS 123R adoption on future earnings, noting $2.5 million in future pre-tax expense for nonvested options.
• Share Repurchases: Monitor the remaining authorized share repurchase capacity (approx. 150,000 shares) and the Company's cash position relative to buyback activity.
• Receivables Quality: Assess the provision for doubtful accounts, which increased to 1.8% of net patient revenues in Q3 2006 from 1.1% in Q3 2005.